658 related articles for article (PubMed ID: 10353302)
41. Salmeterol/fluticasone propionate combination.
Spencer CM; Jarvis B
Drugs; 1999 Jun; 57(6):933-40; discussion 941-3. PubMed ID: 10400406
[TBL] [Abstract][Full Text] [Related]
42. Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma.
Li JT; Ford LB; Chervinsky P; Weisberg SC; Kellerman DJ; Faulkner KG; Herje NE; Hamedani A; Harding SM; Shah T
J Allergy Clin Immunol; 1999 Jun; 103(6):1062-8. PubMed ID: 10359887
[TBL] [Abstract][Full Text] [Related]
43. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids.
Wolfe J; Rooklin A; Grady J; Munk ZM; Stevens A; Prillaman B; Duke S; Harding S
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1153-61. PubMed ID: 10856150
[TBL] [Abstract][Full Text] [Related]
44. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
46. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.
Lanz MJ; Eisenlohr C; Llabre MM; Toledo Y; Lanz MA
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):283-8. PubMed ID: 11686419
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
Wasserman RL; Baker JW; Kim KT; Blake KV; Scott CA; Wu W; Faris MA; Crim C
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):808-18. PubMed ID: 16802768
[TBL] [Abstract][Full Text] [Related]
48. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
[TBL] [Abstract][Full Text] [Related]
49. Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma in adults and children.
Adams N; Bestall JM; Lasserson TJ; Jones PW
Cochrane Database Syst Rev; 2005 Apr; (2):CD002310. PubMed ID: 15846637
[TBL] [Abstract][Full Text] [Related]
50. Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.
Dyer MJ; Halpin DM; Stein K
BMC Fam Pract; 2006 Jun; 7():34. PubMed ID: 16753053
[TBL] [Abstract][Full Text] [Related]
51. Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a day.
Purucker ME; Rosebraugh CJ; Zhou F; Meyer RJ
Chest; 2003 Oct; 124(4):1584-93. PubMed ID: 14555594
[TBL] [Abstract][Full Text] [Related]
52. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
[TBL] [Abstract][Full Text] [Related]
53. Early asthma control and maintenance with eformoterol following reduction of inhaled corticosteroid dose.
Price D; Dutchman D; Mawson A; Bodalia B; Duggan S; Todd P;
Thorax; 2002 Sep; 57(9):791-8. PubMed ID: 12200524
[TBL] [Abstract][Full Text] [Related]
54. Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/250 microg twice daily and budesonide 800 microg twice daily in the treatment of adults and adolescents with asthma. International Study Group.
Lundbäck B; Jenkins C; Price MJ; Thwaites RM
Respir Med; 2000 Jul; 94(7):724-32. PubMed ID: 10926346
[TBL] [Abstract][Full Text] [Related]
55. A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma.
Nathan RA; Li JT; Finn A; Jones R; Payne JE; Wolford JP; Harding SM
Chest; 2000 Aug; 118(2):296-302. PubMed ID: 10936116
[TBL] [Abstract][Full Text] [Related]
56. Efficacy and safety of low-dose fluticasone propionate compared with zafirlukast in patients with persistent asthma.
Brabson JH; Clifford D; Kerwin E; Raphael G; Pepsin PJ; Edwards LD; Srebro S; Rickard K
Am J Med; 2002 Jul; 113(1):15-21. PubMed ID: 12106618
[TBL] [Abstract][Full Text] [Related]
57. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
Harrison TW; Wisniewski A; Honour J; Tattersfield AE
Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity.
Lawrence M; Wolfe J; Webb DR; Chervinsky P; Kellerman D; Schaumberg JP; Shah T
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):744-51. PubMed ID: 9309988
[TBL] [Abstract][Full Text] [Related]
59. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group.
Dahl R; Lundback B; Malo JL; Mazza JA; Nieminen MM; Saarelainen P; Barnacle H
Chest; 1993 Nov; 104(5):1352-8. PubMed ID: 8222787
[TBL] [Abstract][Full Text] [Related]
60. Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma.
Adams N; Bestall JM; Lasserson TJ; Jones PW
Cochrane Database Syst Rev; 2004; (2):CD002310. PubMed ID: 15106173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
